Morin inhibits the progression of 5-fluorouracil–resistant colorectal cancer by suppressing autophagy
The International Journal of Biochemistry & Cell Biology · 2025
DOI: 10.1016/j.biocel.2025.106783 ↗Kurz gefasst
Fachartikel in der Zeitschrift The International Journal of Biochemistry & Cell Biology, 2025. Verfasst von Rui Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation, Beijing Jishuitan Hospital Guizhou Hospital, Guiyang, Guizhou 550014, China. Hauptthemen laut MEDLINE: Fluorouracil, Colorectal Neoplasms, Autophagy, Flavonoids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Resistance to 5-fluorouracil (5-FU) poses a significant challenge in colorectal cancer (CRC) treatment. Morin is a flavonoid with anti-tumor properties. However, its role in overcoming acquired 5-FU resistance in CRC remains unclear. METHODS: 5-FU-resistant CRC (5-FU/CRC) cell lines (HT29/5-FU and HCT116/5-FU) were established using the IC50 concentration increment method. After treatment with Morin and autophagy inhibitors (3-MA) or agonists (RAPA), cell viability, apoptosis, colony formation, migration, invasion, and autophagy were evaluated. In vivo, xenograft models of 5-FU/CRC assessed Morin's therapeutic effects. RESULTS: 5-FU/CRC cells were successfully constructed. Morin inhibited the viability, migration, and invasion of 5-FU/CRC cells and promoted apoptosis. Morin also inhibited autophagy in 5-FU/CRC cells. Besides, autophagy activated by RAPA could eliminate the effect of Morin on 5-FU/CRC cells, while 3-MA enhanced the effects of Morin. In nude mouse models, Morin inhibited the growth and improved the pathological structure of 5-FU/CRC xenografts by inhibiting autophagy. CONCLUSION: Morin suppresses the progression of 5-FU/CRC by inhibiting autophagy, suggesting its potential as a therapeutic agent to combat 5-FU resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rehabilitation, Beijing Jishuitan Hospital Guizhou Hospital, Guiyang, Guizhou 550014, China.
- The Second Clinical School of Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou 550003, China.
- Department of Geriatrics, The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou 550003, China.
- Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education, School of Basic Medical, Guizhou Medical University, Guiyang, Guizhou 550002, China; Key Laboratory of Medical Molecular Biology, School of Basic Med…
- Department of Rehabilitation, Beijing Jishuitan Hospital Guizhou Hospital, Guiyang, Guizhou 550014, China. Electronic address: jyxhs0420@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, R., Wang, F., Huang, L., Zhao, L., Qin, T., Liu, S., Xu, K., Wang, B., Li, L., & He, S. (2025). Morin inhibits the progression of 5-fluorouracil–resistant colorectal cancer by suppressing autophagy. The International Journal of Biochemistry & Cell Biology. https://doi.org/10.1016/j.biocel.2025.106783
Vancouver
Li R, Wang F, Huang L, Zhao L, Qin T, Liu S, et al. Morin inhibits the progression of 5-fluorouracil–resistant colorectal cancer by suppressing autophagy. The International Journal of Biochemistry & Cell Biology. 2025. doi:10.1016/j.biocel.2025.106783
BibTeX
@article{Li2025,
author = {Li, Rui and Wang, Fengxia and Huang, Lu and Zhao, Lvheng and Qin, Ting and Liu, Shan and Xu, Kunyao and Wang, Bi and Li, Ling and He, Sha},
title = {Morin inhibits the progression of 5-fluorouracil–resistant colorectal cancer by suppressing autophagy},
journal = {The International Journal of Biochemistry & Cell Biology},
year = {2025},
doi = {10.1016/j.biocel.2025.106783}
}
EUVIMED